Response as a predictor of survival in patients with recurrent glioblastoma treated with bevacizumab.
Prados M; Cloughesy T; Samant M; Fang L; Wen PY; Mikkelsen T; Schiff D; Abrey LE; Yung WK; Paleologos N; Nicholas MK; Jensen R; Vredenburgh J; Das A; Friedman HS; Neuro-Oncology, 2011, vol. 13, issue 1, p 143, ISSN 15235866. ISBN 15235866.

Full Text Resources Located for this Citation

View article on EBSCOhost(Login required)
View article via CrossRef